FilingReader Intelligence
Livzon Pharma continues share repurchase program
April 10, 2025 at 05:35 PM UTC•By FilingReader AI
Livzon Pharmaceutical Group (SZSE:000513) filed a next-day disclosure report detailing share repurchase activities executed on April 10, 2025. The company repurchased 290,100 A-shares on the Shenzhen Stock Exchange for a total consideration of RMB9,997,408, with prices ranging from RMB34.25 to RMB34.66 per share. In addition, 307,052,417 H-shares are still being repurchased but not yet cancelled.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SZSE:000513•Shenzhen Stock Exchange
News Alerts
Get instant email alerts when Livzon Pharmaceutical Group publishes news
Free account required • Unsubscribe anytime